Dr. Douillard is Professor of Medical Oncology at the University of Nantes (France), Director of Clinical and Translational Research at Rene Gauducheau Cancer Center Nantes (France). View profile. 1. In your view, which development in the area of lung cancer that has occurred in 2009 could have the most significant impact on oncology?There were 2 key developments that will induce changes in the medical management of non–small cell lung cancer (NSCLC). The first development is an improved understanding...